# Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients

> **NCT04509414** · PHASE4 · COMPLETED · sponsor: **Peking University** · enrollment: 100 (actual)

## Conditions studied

- Deep Sedation
- Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04509414
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-10
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04509414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04509414, "Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04509414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*